The Legacy of CVI.

Q2 Biochemistry, Genetics and Molecular Biology

Clinical and Vaccine Immunology Pub Date : 2017-12-05 Print Date: 2017-12-01 DOI:10.1128/CVI.00276-17

Marcela F Pasetti, Steven D Douglas, Susan F Plaeger

引用次数: 0

Abstract

Clinical and Vaccine Immunology (CVI) will merge with the American Society for Microbiology (ASM) open-access journal mSphere in January 2018. We commemorate this transition by exploring the history of CVI and that of its predecessor, Clinical and Diagnostic Laboratory Immunology (CDLI), and by acknowledging their contributors. Research on vaccines, clinical immunology, and clinical diagnostic immunology published through mSphere will be available without restrictions to an ever-larger audience, which will expedite progress in the field. ASM remains committed to supporting its members and the research community by facilitating the dissemination of scientific knowledge in these important areas.

Abstract Image

查看原文本刊更多论文

CVI的遗产。

临床与疫苗免疫学(CVI)将于2018年1月与美国微生物学会(ASM)开放获取期刊mSphere合并。我们通过探索CVI及其前身临床与诊断实验室免疫学(CDLI)的历史来纪念这一转变，并对他们的贡献者表示感谢。通过mSphere发表的关于疫苗、临床免疫学和临床诊断免疫学的研究将不受限制地提供给越来越多的读者，这将加快该领域的进展。ASM继续致力于通过促进这些重要领域的科学知识传播来支持其成员和研究界。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Vaccine Immunology 医学-传染病学

CiteScore

2.88

自引率

0.00%

发文量

审稿时长

1.5 months

期刊介绍： Cessation. First launched as Clinical and Diagnostic Laboratory Immunology (CDLI) in 1994, CVI published articles that enhanced the understanding of the immune response in health and disease and after vaccination by showcasing discoveries in clinical, laboratory, and vaccine immunology. CVI was committed to advancing all aspects of vaccine research and immunization, including discovery of new vaccine antigens and vaccine design, development and evaluation of vaccines in animal models and in humans, characterization of immune responses and mechanisms of vaccine action, controlled challenge studies to assess vaccine efficacy, study of vaccine vectors, adjuvants, and immunomodulators, immune correlates of protection, and clinical trials.